Literature DB >> 25597333

Intratumoral dendritic cells in the anti-tumor immune response.

Yang Liu1, Xuetao Cao2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25597333      PMCID： PMC4496534          DOI： 10.1038/cmi.2014.130

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  18 in total

Review 1.  Dendritic cell vaccines in cancer immunotherapy: from biology to translational medicine.

Authors:  Hongmei Xu; Xuetao Cao
Journal:  Front Med       Date:  2011-12       Impact factor: 4.592

2.  Cancer immunotherapy.

Authors:  Marcia McNutt
Journal:  Science       Date:  2013-12-20       Impact factor: 47.728

Review 3.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

4.  Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity.

Authors:  Miranda L Broz; Mikhail Binnewies; Bijan Boldajipour; Amanda E Nelson; Joshua L Pollack; David J Erle; Andrea Barczak; Michael D Rosenblum; Adil Daud; Diane L Barber; Sebastian Amigorena; Laura J Van't Veer; Anne I Sperling; Denise M Wolf; Matthew F Krummel
Journal:  Cancer Cell       Date:  2014-10-16       Impact factor: 31.743

5.  Cancer treatment: The killer within.

Authors:  Heidi Ledford
Journal:  Nature       Date:  2014-04-03       Impact factor: 49.962

6.  Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells.

Authors:  Brian Ruffell; Debbie Chang-Strachan; Vivien Chan; Alexander Rosenbusch; Christine M T Ho; Nancy Pryer; Dylan Daniel; E Shelley Hwang; Hope S Rugo; Lisa M Coussens
Journal:  Cancer Cell       Date:  2014-10-16       Impact factor: 31.743

Review 7.  Influence of tumour micro-environment heterogeneity on therapeutic response.

Authors:  Melissa R Junttila; Frederic J de Sauvage
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

8.  Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer.

Authors:  Kristi Baker; Timo Rath; Magdalena B Flak; Janelle C Arthur; Zhangguo Chen; Jonathan N Glickman; Inti Zlobec; Eva Karamitopoulou; Matthew D Stachler; Robert D Odze; Wayne I Lencer; Christian Jobin; Richard S Blumberg
Journal:  Immunity       Date:  2013-11-27       Impact factor: 31.745

9.  Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells.

Authors:  Jérémy Goc; Claire Germain; Thi Kim Duy Vo-Bourgais; Audrey Lupo; Christophe Klein; Samantha Knockaert; Luc de Chaisemartin; Hanane Ouakrim; Etienne Becht; Marco Alifano; Pierre Validire; Romain Remark; Scott A Hammond; Isabelle Cremer; Diane Damotte; Wolf-Herman Fridman; Catherine Sautès-Fridman; Marie-Caroline Dieu-Nosjean
Journal:  Cancer Res       Date:  2013-12-23       Impact factor: 12.701

10.  Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma.

Authors:  Yanmei Han; Zhubo Chen; Yuan Yang; Zhengping Jiang; Yan Gu; Yangfang Liu; Chuan Lin; Zeya Pan; Yizhi Yu; Minghong Jiang; Weiping Zhou; Xuetao Cao
Journal:  Hepatology       Date:  2013-12-23       Impact factor: 17.425
View more
  21 in total

Review 1.  Dendritic cells in cancer: the role revisited.

Authors:  Filippo Veglia; Dmitry I Gabrilovich
Journal:  Curr Opin Immunol       Date:  2017-02-10       Impact factor: 7.486

Review 2.  Cellular and molecular regulation of innate inflammatory responses.

Authors:  Juan Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2016-10-31       Impact factor: 11.530

3.  Prognostic and therapeutic value of CD103+ cells in renal cell carcinoma.

Authors:  Jin Zhou; Lipeng Liu; Tuo Yang; Bingxin Lu
Journal:  Exp Ther Med       Date:  2018-04-02       Impact factor: 2.447

Review 4.  Immunosuppressive cells in tumor immune escape and metastasis.

Authors:  Yang Liu; Xuetao Cao
Journal:  J Mol Med (Berl)       Date:  2015-12-22       Impact factor: 4.599

5.  Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti-PD1-Resistant Lung Tumor Model.

Authors:  Sharareh Niknam; Hampartsoum B Barsoumian; Jonathan E Schoenhals; Heather L Jackson; Niranjan Yanamandra; Mauricio S Caetano; Ailin Li; Ahmed I Younes; Alexandra Cadena; Taylor R Cushman; Joe Y Chang; Quynh N Nguyen; Daniel R Gomez; Adi Diab; John V Heymach; Patrick Hwu; Maria Angelica Cortez; James W Welsh
Journal:  Clin Cancer Res       Date:  2018-05-21       Impact factor: 12.531

Review 6.  NK Cell Exhaustion.

Authors:  Jiacheng Bi; Zhigang Tian
Journal:  Front Immunol       Date:  2017-06-28       Impact factor: 7.561

7.  STAT3 and NF-κB are Simultaneously Suppressed in Dendritic Cells in Lung Cancer.

Authors:  Rui Li; Fang Fang; Ming Jiang; Chenguang Wang; Jiajia Ma; Wenyao Kang; Qiuyan Zhang; Yuhui Miao; Dong Wang; Yugang Guo; Linnan Zhang; Yang Guo; Hui Zhao; Zhigang Tian; Weihua Xiao
Journal:  Sci Rep       Date:  2017-03-28       Impact factor: 4.379

Review 8.  The Emerging Role of CD244 Signaling in Immune Cells of the Tumor Microenvironment.

Authors:  Laura Agresta; Kasper H N Hoebe; Edith M Janssen
Journal:  Front Immunol       Date:  2018-11-28       Impact factor: 7.561

9.  Antimicrobial Peptide TP4 Induces ROS-Mediated Necrosis by Triggering Mitochondrial Dysfunction in Wild-Type and Mutant p53 Glioblastoma Cells.

Authors:  Bor-Chyuan Su; Chieh-Yu Pan; Jyh-Yih Chen
Journal:  Cancers (Basel)       Date:  2019-02-01       Impact factor: 6.639

10.  STAT3-blocked whole-cell hepatoma vaccine induces cellular and humoral immune response against HCC.

Authors:  Qiuju Han; Yaqun Wang; Min Pang; Jian Zhang
Journal:  J Exp Clin Cancer Res       Date:  2017-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.